
📋Overview
The condition results from a lack of alpha-L-iduronidase, which leads to the progressive accumulation of glycosaminoglycans within cellular lysosomes. This buildup can cause widespread damage to various tissues and organ systems as the substances collect over time.
Clinical literature often identifies this severe phenotype as a form of mucopolysaccharidosis type I (MPS I). The resulting cellular dysfunction typically affects multiple physiological structures, leading to the multisystemic nature of the disorder.
Educational overview only. This page summarizes publicly available health information for general understanding and awareness. It does not provide medical advice, diagnosis, or treatment. For personalized guidance or care decisions, consult a qualified healthcare professional.
Medical codes (for reference)
UMLS CUI: C0086795Codes are provided for reference and interoperability. They are not a diagnosis.
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.